{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:38:00Z","timestamp":1790933880700,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,2,4]],"date-time":"2003-02-04T00:00:00Z","timestamp":1044316800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the roles of RhoA small GTPase (RhoA) in upper urinary tract cancer by analysing the mRNA and protein levels of RhoA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>The mRNA and protein levels of RhoA in matched sets of tumour, non\u2010tumour and metastatic lymph node tissues of surgical specimens were analysed in 47 consecutive patients with renal pelvic\/ureteric cancer, using the polymerase chain reaction after reverse transcription and Western blotting. The relationship between mRNA and protein levels of RhoA in tumour tissues and the clinicopathological features of the patients was also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The mRNA levels of RhoA and RhoA protein were greater in tumour and metastatic lymph node tissues than in non\u2010tumour tissues (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.001). The expression levels of RhoA mRNA and protein levels in primary tumours was related to poorly differentiated grade (both\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.05) and muscle invasion (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.01 and &lt; 0.001, respectively). Kaplan\u2010Meier plots of survival in patients with low or high RhoA showed that high mRNA and protein levels were associated with a shorter disease\u2010free (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.01) and overall survival (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.001). Multivariate analysis using the Cox proportional hazards model showed that a high RhoA protein level was an independent prognostic factor, second to stage, in disease\u2010free and overall survival (both\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>These findings suggest that RhoA is involved in the invasion and metastasis of upper urinary tract cancer, indicating that RhoA may be a useful prognostic factor in this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1046\/j.1464-410x.2003.03063.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:13:33Z","timestamp":1047352413000},"page":"234-238","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer"],"prefix":"10.1111","volume":"91","author":[{"given":"T.","family":"Kamai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tsujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u2010I.","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,2,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)62008-1"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81470-1"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201499"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.509"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02030.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200103048"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.4049\/jimmunol.162.5.2964","article-title":"Lymphocyte migration through brain endothelial cell monolayers involves signalling through endothelial ICAM\u20101 via Rho\u2010dependent pathway","volume":"162","author":"Adamson P","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.23"},{"key":"e_1_2_6_11_2","volume-title":"TNM Classification of Malignant Tumours.","author":"Sobin LH","year":"1997"},{"key":"e_1_2_6_12_2","first-page":"2004","article-title":"Overexpression of small GTP\u2010binding protein RhoA promotes invasion of tumor cells","volume":"59","author":"Yoshioka K","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)88661-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.11.7.3682"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.42.25172"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(89)90440-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/5587"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2000.tb01018.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00107-5"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1464-410X.2003.03063.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:54:12Z","timestamp":1761731652000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1046\/j.1464-410X.2003.03063.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1046\/j.1464-410X.2003.03063.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1464-410x.2003.03063.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"2003-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}